On February 19 2022, Maurice R. Ferré, MD notified MedTech Acquisition Corporation (“MedTech” or the “Company”) that he was resigning as a member of the Company's Board of Directors and all other positions with the Company effective immediately. Dr. Ferré's resignation was not the result of any disagreement with the Company. Dr. Ferré will continue to serve as Chairman of the Board of Memic Innovative Surgery Ltd. (“Memic”).

The Board of Directors of the Company would like to formally extend its gratitude to Dr. Ferré for his service and contributions to the Company and the Board of Directors. In connection with Dr. Ferré's resignation, the Board of Directors of the Company appointed Manuel Aguero to the Board's Audit Committee and to the Board's Compensation Committee. The Board of Directors determined that Mr. Aguero is independent as he (among other things) satisfies the applicable requirements under applicable Nasdaq rules and the rules and regulations of the SEC.

Following such appointment, the committees of the Board currently consist of the following directors: Audit Committee: Ivan Delevic (Chairman), Karim Karti and Manuel Aguero, all of whom are independent directors. Compensation Committee: Manuel Aguero (Chairman) and Martin Roche, M.D., each of whom are independent directors.